Brind.

Eric Crombez, who serves as Chief Medical Officer, was involved in a conference in London with Ultragenyx Pharmaceutical.

1 report, 1 independent Updated Aug 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Eric Crombez, who serves as Chief Medical Officer, was involved in a conference in London with Ultragenyx Pharmaceutical.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireUltragenyx to Participate at Investor Conferences in September NOVATO, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on